Driven by science & technology

Medical cannabis analytical method development and validation by Cannassure

The analysis and validation methods developed, identify seven cannabinoids-THC and CBD and their derivatives THCA and CBDA, as well as CBN, CBC and CBG. The cannabinoids can be detected in cannabis flowers, extracts, and tinctures to ensure quality, stability and consistency of Cannassure’s products and meet GMP and other regulatory requirements and specifications for the pharmaceutical industry.

New medical grade cannabis products

We are developing comprehensive standardized processing procedures for our medical grade cannabis products. These products will meet IMC-GMP standards and will be tested for stability for the duration of their shelf life to ensure consistently reliable and effective for treatment.

Medical grade cannabis combination products for individualized therapy

We are developing new medical grade cannabis combination products that will be delivered in precise dosages with easy to use devices. These new products will provide safer and more effective treatment by improving the delivery and bioavailability. The combination is compatible to the treated condition.

Cannabinoid based pharmaceutical medicines - Women's Health

Cannassure is acting to provide pharmaceutical cannabinoid drug-device combinations for gynecological solutions. We are developing a unique, proprietary drug-device combination, that delivers specific therapeutic cannabinoids to the female reproductive system. As our research and development progresses we will be able to share more information on these and other advancements.

Our Philosophy

Cannassure is driven by science and technology to develop new medical grade cannabis products to improve treatment, and address a broad range of medical needs. Our dedicated R&D program is aimed for developing proprietary, pharmaceutical cannabinoid based therapeutics, that meet unmet medical needs.